Prognostic parameters for the management of advanced testis tumours

Current Opinion in Urology

Volumn 10, Issue 5, 2000, Pages 465-471

  Mickisch, Gerald H J ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL FACTOR; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; EPITOPE; GEMCITABINE; IFOSFAMIDE; PACLITAXEL; TUMOR MARKER;

ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; DISEASE MARKER; GERM CELL TUMOR; LIVER METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCINTIGRAPHY; TESTIS CANCER; TESTIS TUMOR; TUMOR GROWTH; TUMOR VOLUME;

DISEASE PROGRESSION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RISK FACTORS; SOCIAL CLASS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033817082     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200009000-00017     Document Type: Article

References (23)

1. Risk of testicular cancer in subfertile men: Case control study
2. Risk factors for testicular germ cell tumours by histological tumour type
3. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: A nested case-control study
4. The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996
5. Who should manage germ cell tumours of the testis?
6. Impact of the treating institution on survival of patients with 'Poor-Prognosis' metastatic nonseminoma
7. Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer
8. 125l-Labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
9. Germ cell tumor: Differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling
10. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors
11. Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study
12. Expression of mage genes in testicular germ cell tumours
13. Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors
14. Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors
15. Prognostic factors in prostate and testis cancer
16. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease
17. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer
18. Phase II trial of gemcitabine in refractory germ cell tumors
19. Treatment of disseminated non-seminomatous testicular cancer: The european experience
20. Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of taxol-BEP
21. High-dose chemotherapy with autologous stem-cell support for germ cell tumors: A critical review
22. Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer
23. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours